Joincare Pharmaceutical Group Industry Co Ltd Cash Flow-to-Debt Ratio
Joincare Pharmaceutical Group Industry Co Ltd cash flow-to-debt ratio. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥1.09 Billion could theoretically repay 0% of its total liabilities (CN¥11.93 Billion) in one year. Check Joincare Pharmaceutical Group Industry C (600380) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Cash flow-to-debt ratio of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. Historical debt coverage capacity for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Check 600380 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow-to-Debt Ratio by Year (1999–2025)
Joincare Pharmaceutical Group Industry Co Ltd cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for Joincare Pharmaceutical Group Industry Co Ltd. For the full cash flow conversion analysis, see Joincare Pharmaceutical Group Industry C cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥3.89 Billion | CN¥11.05 Billion | ▲ +19.3% |
| 2024 | 0.30x | CN¥3.64 Billion | CN¥12.32 Billion | ▲ +3.1% |
| 2023 | 0.29x | CN¥3.93 Billion | CN¥13.72 Billion | ▼ -1.3% |
| 2022 | 0.29x | CN¥3.98 Billion | CN¥13.71 Billion | ▲ +23.7% |
| 2021 | 0.23x | CN¥2.56 Billion | CN¥10.92 Billion | ▼ -30.8% |
| 2020 | 0.34x | CN¥3.02 Billion | CN¥8.92 Billion | ▲ +18.1% |
| 2019 | 0.29x | CN¥2.31 Billion | CN¥8.05 Billion | ▲ +36.7% |
| 2018 | 0.21x | CN¥1.83 Billion | CN¥8.69 Billion | ▼ -3.5% |
| 2017 | 0.22x | CN¥1.87 Billion | CN¥8.59 Billion | ▼ -10.8% |
| 2016 | 0.24x | CN¥1.64 Billion | CN¥6.74 Billion | ▲ +25.3% |
| 2015 | 0.19x | CN¥1.26 Billion | CN¥6.49 Billion | ▲ +10.3% |
| 2014 | 0.18x | CN¥979.46 Million | CN¥5.54 Billion | ▲ +31.3% |
| 2013 | 0.13x | CN¥635.52 Million | CN¥4.72 Billion | ▼ -23.7% |
| 2012 | 0.18x | CN¥734.36 Million | CN¥4.16 Billion | ▼ -9.0% |
| 2011 | 0.19x | CN¥650.36 Million | CN¥3.35 Billion | ▼ -68.6% |
| 2010 | 0.62x | CN¥1.11 Billion | CN¥1.79 Billion | ▲ +77.7% |
| 2009 | 0.35x | CN¥605.66 Million | CN¥1.74 Billion | ▲ +49.5% |
| 2008 | 0.23x | CN¥455.01 Million | CN¥1.96 Billion | ▲ +5.2% |
| 2007 | 0.22x | CN¥429.26 Million | CN¥1.94 Billion | ▲ +51.0% |
| 2006 | 0.15x | CN¥272.50 Million | CN¥1.86 Billion | ▼ -45.1% |
| 2005 | 0.27x | CN¥363.13 Million | CN¥1.36 Billion | ▲ +58.8% |
| 2004 | 0.17x | CN¥241.71 Million | CN¥1.44 Billion | ▲ +34.7% |
| 2003 | 0.12x | CN¥172.25 Million | CN¥1.38 Billion | ▼ -73.0% |
| 2002 | 0.46x | CN¥236.13 Million | CN¥511.40 Million | ▼ -28.6% |
| 2001 | 0.65x | CN¥223.79 Million | CN¥346.20 Million | ▲ +89.0% |
| 2000 | 0.34x | CN¥171.61 Million | CN¥501.77 Million | ▲ +53.3% |
| 1999 | 0.22x | CN¥109.82 Million | CN¥492.14 Million | — |